by Alex Watkins ONeill | Feb 11, 2025 | Content
The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit is now available. This comprehensive resource is designed to help communities expand access to lifesaving medications like...
by Alex Watkins ONeill | Feb 5, 2025 | Content
North Carolina’s state and local governments are set to receive up to $150 million as part of a $7.4 billion settlement with Purdue Pharma and the Sackler family. This lawsuit stems from the impact of OxyContin on communities across the state. Purdue Pharma,...
by Alex Watkins ONeill | Jan 21, 2025 | Content
Medical research can sometimes become disconnected from the interests and needs of the people it is intended to serve. This is true across diseases and disorders, and addiction research is no exception. Too often, scientists who study drugs and addiction have not...
by Alex Watkins ONeill | Jan 14, 2025 | Content
According to the US Centers for Disease Control and Prevention (CDC), an estimated 107,543 deaths due to unintentional drug overdose occurred in the US in 2023. People who use drugs are also at increased risk of infection (e.g., HIV; hepatitis A, B, and C; bacterial...
by Alex Watkins ONeill | Jan 7, 2025 | Content
Alcohol-impaired driving deaths per year remained at about 10,000 from 2010 to 2020 but increased to 13,500 in 2022. This paper analyzed data from the National Survey on Drug Use and Health to study driving under the influence of alcohol (DUIA), marijuana (DUIM), and...
by Alex Watkins ONeill | Dec 31, 2024 | Content
Medications for opioid use disorder (MOUD), namely methadone, buprenorphine, or naltrexone, remain the most effective treatment for opioid use disorder (OUD), yet they remain underutilized. This cross-sectional study aimed to describe MOUD availability at psychiatric...
Recent Comments